Company / Goodwill
NovaBay Pharmaceuticals, Inc. Goodwill History
FY2020-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
-
FY2023
5-year range
$0 / $4.5M
FY2020-FY2023
Trend
-100.0%
vs FY2022
Sector context
#76 of 76
Health Care
What the data says
Declined from $5M to $0 over the past 2 years.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 0% in Health CareTop 100% of 76
▼
Key checks
Key Insights
- In FY2023, goodwill decreased 100.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | $0 | -100.0% |
| FY2022 | $348.0K | -92.3% |
| FY2021 | $4.5M | - |
| FY2020 | $0 | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026